HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Greeve, J. Articles by Chowdhury, J. R. Search for Related Content PubMed PubMed Citation Articles by Greeve, J. Articles by Chowdhury, J. R. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol 37, 2001-2017, Copyright © 1996 by Lipid Research, Inc.

ARTICLES

Hepatic gene transfer of the catalytic subunit of the apolipoprotein B mRNA editing enzyme results in a reduction of plasma LDL levels in normal and watanabe heritable hyperlipidemic rabbits

J Greeve, VK Jona, NR Chowdhury, MS Horwitz and JR Chowdhury
Medizinische Klinik, Universitats-Krankenhaus Eppendorf, Hamburg, Germany.

Apolipoprotein (apo) B exists in two forms, the full length protein apoB-100 and the carboxyterminal-truncated apoB-48 that is synthesized in the intestine due to editing of the apoB mRNA which generates a premature stop codon. To determine whether gene transfer of the catalytic subunit of the apoB mRNA editing enzyme APOBEC-1 (apoB mRNA editing enzyme catalytic polypeptide 1) into the liver of rabbits reconstitutes hepatic apoB mRNA editing and how this affects the plasma levels of apoB-containing lipoproteins, we constructed an APOBEC-1 recombinant adenovirus (Ad APOBEC-1). After injection of Ad APOBEC-1 into normal New Zealand White (NZW) or Watanabe heritable hyperlipidemic (WHHL) rabbits, up to 50% of the hepatic apoB mRNA was edited and freshly isolated hepatocytes secreted predominantly apoB-48- containing lipoproteins. VLDL isolated from Ad APOBEC-1-treated NZW and WHHL rabbits contained both apoB-100 and apoB-48, whereas that from control rabbits infected with a beta-galactosidase recombinant adenovirus (Ad LacZ) contained exclusively apoB-100. VLDL from WHHL rabbits treated with Ad APOBEC-1 had the same particle size, lipid composition, and content of apolipoprotein E as VLDL from Ad LacZ- infected control animals. An increase of VLDL was observed in NZW and WHHL rabbits after infection with Ad APOBEC-1 as well as Ad LacZ. After injection of Ad APOBEC-1, LDL became undetectable in the plasma of NZW rabbits and was reduced by an average of 65% in the plasma of WHHL rabbits compared to Ad LacZ-infected controls. LDL from Ad APOBEC-1- infected WHHL rabbits contained only apoB-100. VLDL isolated from Ad APOBEC-1-infected WHHL rabbits were rapidly cleared from the circulation after injection into NZW rabbits. These results provide further evidence that the switch in the hepatic synthesis from exclusively apoB-100 to partly apoB-48 can result in a reduction of LDL formation that requires the full-length apoB-100.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				E. C. Salido, X. M. Li, Y. Lu, X. Wang, A. Santana, N. Roy-Chowdhury, A. Torres, L. J. Shapiro, and J. Roy-Chowdhury Alanine-glyoxylate aminotransferase-deficient mice, a model for primary hyperoxaluria that responds to adenoviral gene transfer PNAS, November 28, 2006; 103(48): 18249 - 18254. [Abstract] [Full Text] [PDF]

				H. Lellek, S. Welker, I. Diehl, R. Kirsten, and J. Greeve Reconstitution of mRNA Editing in Yeast Using a Gal4-ApoB-Gal80 Fusion Transcript as the Selectable Marker J. Biol. Chem., June 21, 2002; 277(26): 23638 - 23644. [Abstract] [Full Text] [PDF]

				J. S. Millar, C. Maugeais, I. V. Fuki, and D. J. Rader Normal Production Rate of Apolipoprotein B in LDL Receptor-Deficient Mice Arterioscler. Thromb. Vasc. Biol., June 1, 2002; 22(6): 989 - 994. [Abstract] [Full Text] [PDF]

				B.-B. Teng, S. Ochsner, Q. Zhang, K. V. Soman, P. P. Lau, and L. Chan Mutational analysis of apolipoprotein B mRNA editing enzyme (APOBEC1): structure–function relationships of RNA editing and dimerization J. Lipid Res., April 1, 1999; 40(4): 623 - 635. [Abstract] [Full Text]

				J. Greeve, D. Axelos, S. Welker, M. Schipper, and H. Greten Distinct Promoters Induce APOBEC-1 Expression in Rat Liver and Intestine Arterioscler. Thromb. Vasc. Biol., July 1, 1998; 18(7): 1079 - 1092. [Abstract] [Full Text] [PDF]

				H. Lellek, R. Kirsten, I. Diehl, F. Apostel, F. Buck, and J. Greeve Purification and Molecular Cloning of a Novel Essential Component of the Apolipoprotein B mRNA Editing Enzyme-Complex J. Biol. Chem., June 23, 2000; 275(26): 19848 - 19856. [Abstract] [Full Text] [PDF]